Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Banach, M; Bruckert, E; Descamps, OS; Ellegård, L; Ezhov, M; Föger, B; Fras, Z; Kovanen, PT; Latkovskis, G; März, W; Panagiotakos, DB; Paragh, G; Pella, D; Pirillo, A; Poli, A; Reiner, Ž; Silbernagel, G; Viigimaa, M; Vrablík, M; Catapano, AL.
The role of red yeast rice (RYR) supplementation in plasma cholesterol control: A review and expert opinion.
Atheroscler Suppl. 2019; 39(1):e1-e8-e1-e8 Doi: 10.1016/j.atherosclerosissup.2019.08.023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

März Winfried

Silbernagel Günther

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)

Biological Products - adverse effects

Biological Products - pharmacokinetics

Biological Products - therapeutic use

Biotransformation -

Cardiovascular Diseases - chemically induced

Cholesterol - blood

Clinical Trials as Topic -

Cytochrome P-450 CYP3A - metabolism

Dietary Supplements -

Double-Blind Method -

Expert Testimony -

Food-Drug Interactions -

Gastrointestinal Diseases - chemically induced

Humans -

Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects

Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use

Hypercholesterolemia - therapy

Lovastatin - adverse effects

Lovastatin - chemistry

Lovastatin - pharmacokinetics

Lovastatin - therapeutic use

Medicine, Chinese Traditional -

Molecular Structure -

Multicenter Studies as Topic -

Musculoskeletal Diseases - chemically induced

Prodrugs - pharmacokinetics

Prodrugs - therapeutic use

Randomized Controlled Trials as Topic -

Self Medication -

© Med Uni Graz • Imprint